Bioavailable Testosterone

If you have the symptoms of low testosterone, low sex drive, fatigue, lost muscle, or flat mood, but your standard testosterone result came back normal, this is the number that can explain the gap. It captures the portion of testosterone your body can actually use, which can run low even when the total looks fine.

The two numbers can disagree because of a protein in your blood that grabs onto testosterone and holds it back. When that protein is unusually high or low, a total testosterone figure can point you in the wrong direction, and the usable fraction tells the truer story.

What This Number Actually Captures

Bioavailable testosterone is a slice of the testosterone already circulating in your blood, not a separate hormone. Most testosterone travels bound to two carrier proteins. One, called sex hormone binding globulin (SHBG), grips it tightly and keeps it parked. The other, albumin, holds it loosely.

The loosely held testosterone, plus the small amount floating completely free, makes up the bioavailable fraction, the part that can slip out at your tissues and act. The testosterone locked to SHBG mostly cannot. That is why this measurement can reflect how much androgen your body is truly getting better than a total reading when SHBG is off.

This is a refined, second-line measurement rather than a routine screen. Labs report it either from a direct method or from a calculation using total testosterone, SHBG, and albumin, and results can vary by method, so there is no single universal cutoff. That makes your own trend, measured the same way each time, more useful than one number against a generic range.

Prostate Enlargement

Genetic studies that estimate a man's lifelong bioavailable testosterone have linked higher levels to a greater risk of an enlarged prostate, the common cause of urinary symptoms as men age (a positive association of 0.20; 95% CI 0.06 to 0.34). Because this evidence uses inherited markers rather than a single blood level, it points to a real biological role over a lifetime rather than something one reading predicts.

Kidney Disease in Men

The same kind of genetic analysis found higher bioavailable testosterone associated with chronic kidney disease in men, with roughly 17% higher odds for each step up in genetically estimated levels (odds ratio 1.17 per standard deviation; 95% CI 1.03 to 1.33). The link appeared in men but not women, a reminder that testosterone's effects are strongly sex-specific.

Glaucoma in Women

In women, higher bioavailable testosterone has been tied to open-angle glaucoma, a leading cause of irreversible vision loss, with roughly double the odds at higher levels (odds ratio 2.05 per nmol/L; 95% CI 1.00 to 4.18). The lower edge of that estimate sits right at the no-effect line, so this is a signal worth knowing about rather than a settled fact.

Mortality Signals

One large study of older Chinese men found those in the highest quarter of bioavailable testosterone had about 27% higher risk of death during follow-up than those in the lowest (hazard ratio 1.27; 95% CI 1.05 to 1.54). That runs against the more familiar story, drawn mostly from total and free testosterone, that low levels track higher mortality in men.

Why the Findings Point in Different Directions

It is tempting to read all of this as either more is better or less is better, but neither fits. Bioavailable testosterone is better thought of as a marker of a particular hormonal state, and different states carry different risks for different outcomes and different people. Very low levels tend to travel with frailty, chronic illness, and poor recovery, which is why low readings often accompany worse health in men. Higher levels show associations with prostate growth, kidney disease, and, in some groups, mortality. The number is not a scorecard; it is context that has to be read alongside your sex, age, symptoms, and other labs.

Muscle, Strength, and Thinking

Beyond disease risk, bioavailable testosterone tracks function in ways total testosterone often misses. In premenopausal women, it was the bioavailable fraction, not total testosterone, that lined up with greater muscle mass and strength. In men over 60, higher calculated bioavailable testosterone was associated with faster processing speed and better attention and working memory on standard cognitive tests.

Why One Reading Is Not Enough

A single testosterone measurement is a shaky basis for any decision. Levels swing from day to day around your personal set point, with a within-person variation of roughly 16%, and repeat testing reclassifies a meaningful share of men. Endocrine Society guidance notes that about 30% of men whose first reading falls in the deficient range turn out to be normal when retested. Bioavailable and free testosterone are no steadier than total testosterone, so the same caution applies.

The practical answer is to build a baseline from more than one sample and then watch the trend. Get at least two morning measurements before drawing conclusions, ideally fasting, as the Endocrine Society advises, though the American Urological Association considers the fasting evidence weak and does not require it. Add a third when results are borderline or inconsistent, and retest in 3 to 6 months if you change something that should move the number. Because method matters, use the same lab and the same technique each time so you are comparing like with like.

What to Do With an Unexpected Result

A single surprising value is a prompt to investigate, not to act. If your bioavailable testosterone is low, order the companion tests it depends on, total testosterone, SHBG, and albumin, and repeat the draw on a morning sample. Adding two pituitary signals, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), helps separate a problem in the testes from one higher up in the brain's control center.

Combinations matter more than any single figure. Low bioavailable testosterone alongside real symptoms and confirmed low readings points toward genuine deficiency worth discussing with an endocrinologist, while a low number with no symptoms after a recent illness or new medication usually calls for a repeat once things settle. If you take opioids or steroids, review that first, since both genuinely lower the hormone. In a woman, a high result may warrant a workup for polycystic ovary syndrome, a common cause of elevated androgens.

When a Reading Can Fool You

• Natural day-to-day swings: levels vary around a personal set point by roughly 16%, so a single reading can land in a range that does not reflect your true status.
• Time of day: testosterone peaks in the morning and can be 20 to 25% lower by late afternoon in men in their thirties, so an afternoon draw can look falsely low. Guidelines call for morning sampling.
• Recent food or illness: eating before the test can suppress the reading, and acute illness can push it down temporarily. The Endocrine Society recommends fasting morning draws in good health, though the American Urological Association considers the fasting evidence weak and does not insist on it.
• Assay method: direct and calculated methods do not always agree, and calculated results depend on the formula and inputs the lab uses, so switching labs can shift the number without any real change in you.